Table 3 Comparison of patients regarding intensive care unit need

Demographics

 Ages (years)

67.00(58.00,72.30)

70.00 (61.50, 76.50)

65.00 (56.00, 71.50)

0.002

 Male gender, n (%)

151 (65.65)

52 (71.23)

99 (63.06)

0.22

Comorbidities

 Catheter at 1st HD, n (%)

103 (44.78)

41 (56.16)

62 (39.49)

0.02

 Diabetes mellitus, n (%)

96 (41.74)

33 (45.21)

63 (40.13)

0.49

 IHD, n (%)

41 (17.83)

14 (19.18)

27 (17.20)

0.72

 Hypertension, n (%)

180 (78.26)

46 (63.01)

134 (85.35)

 < 0.001

 CVA, n (%)

53 (23.04)

21 (28.77)

32 (20.38)

0.16

 COPD, n (%)

15 (6.52)

2 (2.74)

13 (8.28)

0.20

Laboratory Variables

 Hb ^a (g/L)

85.00(70.00,106.00)

87.10 ± 25.91

85.00 (71.00, 106.00)

0.25

 WCC (× 10^9/L)

6.40 (4.74, 9.12)

7.89 (5.06, 11.60)

6.21 (4.68, 8.31)

0.006

 Neutrophil (× 10^9/L)

5.22 (3.55, 8.10)

6.63 (4.10, 9.89)

4.66 (3.23, 6.85)

0.001

 Lymphocytes ^a (× 10^9/L)

0.64 (0.41, 0.92)

0.64 ± 0.42

0.66 (0.46, 0.94)

0.03

 Monocytes (× 10^9/L)

0.50 (0.31, 0.70)

0.46 (0.28, 0.70)

0.52 (0.33, 0.70)

0.24

 NWR

0.83 (0.74, 0.92)

0.88 (0.81, 0.94)

0.79 (0.73, 0.90)

 < 0.001

 LWR^a

0.10 (0.06, 0.16)

0.08 (0.04, 0.12)

0.12 ± 0.07

 < 0.001

 MWR

0.07 (0.05, 0.10)

0.06 (0.04, 0.09)

0.08 (0.06, 0.11)

 < 0.001

 NLR

7.81 (4.57, 15.34)

10.92 (6.60, 26.00)

6.24 (4.07, 12.06)

 < 0.001

 MNR

0.09 (0.06, 0.14)

0.07 (0.04, 0.11)

0.11 (0.07, 0.16)

 < 0.001

 MLR

0.74 (0.47, 1.25)

0.74 (0.47, 1.48)

0.74 (0.49, 1.16)

0.52

 PMR

337.92 (209.52, 497.58)

363.66 (212.48, 538.73)

337.00 (208.38, 493.70)

0.79

 PLR

242.91 (153.18, 420.13)

250.88 (148.14, 500.00)

237.50 (154.28, 400.28)

0.33

 PNR

30.73 (19.05, 46.30)

25.76 (14.39, 35.12)

34.75 (23.58, 49.71)

 < 0.001

 Albumin ^a (g/L)

33.60 (30.00, 39.70)

31.62 ± 5.75

34.00 (30.75, 38.78)

 < 0.001

 Ferritin (ug/L)

433.10 (157.70, 997.50)

912.20 (330.75,1470.65)

364.40 (136.38, 753.08)

0.001

 Total cholesterol ^a (mmol/L)

3.45 ± 1.03

3.35 ± 0.96

3.48 ± 1.05

0.39

 HDL ^a (mmol/L)

0.94 (0.76, 1.17)

0.94 ± 0.32

0.95 (0.76, 1.18)

0.35

 LDL ^a (mmol/L)

1.80 (1.34, 2.36)

1.72 ± 0.62

1.86 (1.35, 2.44)

0.10

 Triglycerides (mmol/L)

1.47 (1.05, 2.21)

1.43 (1.02, 2.27)

1.49 (1.07, 2.17)

0.86

 CRP (mg/L)

61.92 (17.21, 138.03)

99.04 (34.13, 228.92)

44.11 (15.10, 122.90)

 < 0.001

 TnT (pg/ml)

79.25 (36.43, 170.25)

101.20 (27.00, 288.40)

76.39 (37.14, 142.13)

0.20

 ESR

74.00 (43.75, 96.50)

82.50 (45.00, 101.25)

72.50 (42.75, 96.00)

0.46

 PCT (ng/L)

1.81 (0.71, 6.25)

3.97 (1.25, 28.68)

1.46 (0.60, 3.61)

 < 0.001

 PLT ^a (× 10^9/L)

155.50 (110.75, 218.75)

161.53 ± 87.22

164.00 (114.50, 215.50)

0.25

 Phosphate ^a (mmol/L)

1.63 (1.30, 2.25)

1.85 ± 0.69

1.45 (0.57, 3.49)

0.73

 Calcium ^a (mmol/L)

1.93 (1.77, 2.10)

1.91 (1.48, 2.04)

1.93 ± 0.26

0.06

 D-dimer (mg/L)

1.75 (1.0, 3.77)

1.42 (0.88, 2.45)

2.53 (1.38, 5.42)

 < 0.001

 EF (%)

57.56 (53.00, 65.00)

60.00 (54.00, 65.00)

61.00 (53.00, 65.00)

0.90

 BNP, n (%)

97 (42.17)

31 (42.47)

66 (42.04)

0.90

 PTH (pg/ml)

244.20 (145.40, 411.91)

103.97 (130.59, 425.18)

253.34 (147.77, 408.36)

0.86

 Creatinine ^a (umol/L)

696.80 (494.25, 989.50)

615.48 ± 367.79

748.00 (576.60, 1041.55)

 < 0.001

Clinical course

 Use of respiratory support

 < 0.001

  Noninvasive, n (%)

40 (17.39)

28 (38.35)

12 (7.64)

  Invasive, n (%)

34 (14.78)

28 (38.35)

6 (3.82)

  Use of corticosteroid, n (%)

100 (43.48)

43 (58.90)

57 (36.31)

0.001

  Use of antiviral, n (%)

67 (29.13)

19 (26.03)

48 (30.57)

0.48

  Use of ACEI or ARB, n (%)

54 (23.48)

13 (17.81)

41 (26.11)

0.17

  Use of anticoagulant, n (%)

38 (16.52)

24 (32.88)

22 (14.01)

0.34

 CT chest

 < 0.001

  Grade 1, n (%)

18 (7.83)

4 (5.48)

14 (8.92)

  Grade 2, n (%)

72 (31.30)

12 (16.44)

60 (38.22)

  Grade 3, n (%)

82 (35.65)

26 (35.62)

56 (35.67)

  Grade 4, n (%)

49 (21.30)

25 (34.25)

24 (15.29)

 Mortality, n (%)

66 (28.70)

32 (43.84)

34 (21.66)

0.001